Atlas Trials

Mark Klempner

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mark Klempner

RecordFirmDate
Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA (NCT06896136)Mark Klempner2025-02-11

Track Mark Klempner automatically

Every clearance here is in the API, with alerts when new ones post.